Last reviewed · How we verify

NCT07259850

Associations of Postoperative Delirium With Perioperative Frailty Worsening and Their Combined Effect on 1-Year Mortality in Older Surgical Patients

Completed Last updated 9 December 2025
What this trial tests

trial in Postoperative Delirium (POD) in 6,196 participants. Completed in 30 April 2023.

Timeline
1 April 2020
Primary endpoint
30 April 2022
30 April 2023

Quick facts

Lead sponsorChinese PLA General Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment6,196
Start date1 April 2020
Primary completion30 April 2022
Estimated completion30 April 2023
Sites1 location across China

Conditions studied

Sponsor

Chinese PLA General Hospital

Who can join

65 and older, any sex, with Postoperative Delirium (POD) or Frailty at Older Adults. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Postoperative delirium (POD) is a frequent complication in older surgical patients and is associated with adverse outcomes, while frailty is also highly prevalent during the perioperative period. This study aimed to determine whether POD accelerates perioperative frailty worsening and to assess the effect of their coexistence on 1-year mortality.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Postoperative Delirium (POD)

Currently open trials in the same condition.

Other Chinese PLA General Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07259850.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing